HomeComparePHIOW vs CL

PHIOW vs CL: Dividend Comparison 2026

PHIOW yields 8620.69% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHIOW wins by $12793007580007856.00M in total portfolio value
10 years
PHIOW
PHIOW
● Live price
8620.69%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12793007580007856.00M
Annual income
$12,507,597,271,400,990,000,000.00
Full PHIOW calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — PHIOW vs CL

📍 PHIOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHIOWCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHIOW + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHIOW pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHIOW
Annual income on $10K today (after 15% tax)
$732,758.62/yr
After 10yr DRIP, annual income (after tax)
$10,631,457,680,690,841,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, PHIOW beats the other by $10,631,457,680,690,841,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHIOW + CL for your $10,000?

PHIOW: 50%CL: 50%
100% CL50/50100% PHIOW
Portfolio after 10yr
$6396503790003928.00M
Annual income
$6,253,798,635,700,495,000,000.00/yr
Blended yield
97.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

PHIOW
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-9.1
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHIOW buys
0
CL buys
0
No recent congressional trades found for PHIOW or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHIOWCL
Forward yield8620.69%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$12793007580007856.00M$41.0K
Annual income after 10y$12,507,597,271,400,990,000,000.00$5,451.69
Total dividends collected$12773964733154094.00M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: PHIOW vs CL ($10,000, DRIP)

YearPHIOW PortfolioPHIOW Income/yrCL PortfolioCL Income/yrGap
1← crossover$872,769$862,068.97$11,014$313.84+$861.8KPHIOW
2$71,250,409$70,316,545.72$12,200$415.44+$71.24MPHIOW
3$5,441,140,196$5,364,902,258.92$13,607$553.09+$5441.13MPHIOW
4$388,717,812,241$382,895,792,231.73$15,301$741.41+$388717.80MPHIOW
5$25,980,665,800,186$25,564,737,741,087.56$17,374$1,002.00+$25980665.78MPHIOW
6$1,624,683,420,105,904$1,596,884,107,699,705.00$19,958$1,367.44+$1624683420.09MPHIOW
7$95,065,580,496,684,460$93,327,169,237,171,150.00$23,243$1,887.87+$95065580496.66MPHIOW
8$5,205,346,525,995,166,000$5,103,626,354,863,713,000.00$27,512$2,642.43+$5205346525995.14MPHIOW
9$266,738,606,174,640,700,000$261,168,885,391,825,900,000.00$33,197$3,759.22+$266738606174640.66MPHIOW
10$12,793,007,580,007,855,000,000$12,507,597,271,400,990,000,000.00$40,973$5,451.69+$12793007580007856.00MPHIOW

PHIOW vs CL: Complete Analysis 2026

PHIOWStock

Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Full PHIOW Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this PHIOW vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHIOW vs SCHDPHIOW vs JEPIPHIOW vs OPHIOW vs KOPHIOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.